{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:48:11Z","timestamp":1785451691584,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72274037"],"award-info":[{"award-number":["72274037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10198-025-01815-1","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T16:21:38Z","timestamp":1754670098000},"page":"411-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparing EQ-5D-5L and SF-6Dv2 utilities with QLU-C10D utilities in hematologic cancer patients"],"prefix":"10.1007","volume":"27","author":[{"given":"Tiantian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3661-3944","authenticated-orcid":false,"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"issue":"1","key":"1815_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks, R.: EuroQol: the current state of play. Health Policy 37(1), 53\u201372 (1996)","journal-title":"Health Policy"},{"issue":"2","key":"1815_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier, J., Roberts, J., Deverill, M.: The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 21(2), 271\u2013292 (2002)","journal-title":"J. Health Econ."},{"key":"1815_CR3","unstructured":"National Institute for Health care and excellence. Guide to the methods of technology appraisal. https:\/\/www.nice.org.uk\/process\/pmg9\/chapter\/foreword. Accessed December 13, 2023."},{"issue":"1","key":"1815_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1017\/S0266462313000640","volume":"30","author":"D Tordrup","year":"2014","unstructured":"Tordrup, D., Mossman, J., Kanavos, P.: Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented? Int. J. Technol. Assess. Health Care 30(1), 10\u201319 (2014)","journal-title":"Int. J. Technol. Assess. Health Care"},{"issue":"3","key":"1815_CR5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s11136-015-1217-y","volume":"25","author":"MT King","year":"2016","unstructured":"King, M.T., Costa, D.S., Aaronson, N.K., et al.: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Qual. Life Res. 25(3), 625\u2013636 (2016)","journal-title":"Qual. Life Res."},{"issue":"5","key":"1815_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N.K., Ahmedzai, S., Bergman, B., et al.: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst. 85(5), 365\u2013376 (1993)","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"1815_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10198-022-01523-0","volume":"24","author":"CW Pan","year":"2023","unstructured":"Pan, C.W., He, J.Y., Zhu, Y.B., Zhao, C.H., Luo, N., Wang, P.: Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. Eur. J. Health Econ. 24(6), 885\u2013893 (2023)","journal-title":"Eur. J. Health Econ."},{"issue":"11","key":"1815_CR8","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.jval.2021.05.022","volume":"24","author":"JW Shaw","year":"2021","unstructured":"Shaw, J.W., Bennett, B., Trigg, A., et al.: A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions. Value Health. 24(11), 1651\u20131659 (2021)","journal-title":"Value Health."},{"issue":"1","key":"1815_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12955-021-01867-w","volume":"19","author":"NB Bulamu","year":"2021","unstructured":"Bulamu, N.B., Vissapragada, R., Chen, G., et al.: Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy. Health Qual. Life Outcomes 19(1), 233 (2021)","journal-title":"Health Qual. Life Outcomes"},{"issue":"4","key":"1815_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s41669-021-00280-9","volume":"5","author":"IA Soare","year":"2021","unstructured":"Soare, I.A., Leeuwenkamp, O., Longworth, L.: Estimation of Health-Related Utilities for 177Lu-DOTATATE in GEP-NET Patients Using Utilities Mapped from EORTC QLQ-C30 to EQ-5D-3L and QLU-C10D Utilities. Pharmacoecon Open. 5(4), 715\u2013725 (2021)","journal-title":"Pharmacoecon Open."},{"issue":"6","key":"1815_CR11","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1007\/s00268-019-04936-w","volume":"43","author":"NB Bulamu","year":"2019","unstructured":"Bulamu, N.B., Chen, G., Ratcliffe, J., Schloite, A., Bright, T., Watson, D.I.: Health-Related Quality of Life Associated with Barrett\u2019s Esophagus and Cancer. World J. Surg. 43(6), 1554\u20131562 (2019)","journal-title":"World J. Surg."},{"issue":"3","key":"1815_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40258-013-0035-z","volume":"11","author":"R Norman","year":"2013","unstructured":"Norman, R., Cronin, P., Viney, R.: A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Appl. Health Econ. Health Policy 11(3), 287\u2013298 (2013)","journal-title":"Appl. Health Econ. Health Policy"},{"issue":"1","key":"1815_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MLR.0000000000000447","volume":"54","author":"F Xie","year":"2016","unstructured":"Xie, F., Pullenayegum, E., Gaebel, K., et al.: A time trade-off-derived value set of the EQ-5D-5L for Canada. Med. Care 54(1), 98\u2013105 (2016)","journal-title":"Med. Care"},{"issue":"4","key":"1815_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","volume":"20","author":"N Luo","year":"2017","unstructured":"Luo, N., Liu, G., Li, M., Guan, H., Jin, X., Rand-Hendriksen, K.: Estimating an EQ-5D-5L Value Set for China. Value Health. 20(4), 662\u2013669 (2017)","journal-title":"Value Health."},{"issue":"4","key":"1815_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s40273-019-00876-4","volume":"38","author":"LF Andrade","year":"2020","unstructured":"Andrade, L.F., Ludwig, K., Goni, J.M.R., et al.: A French value set for the EQ-5D-5L. Pharmacoeconomics 38(4), 413\u2013425 (2020)","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"1815_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40273-018-0615-8","volume":"36","author":"K Ludwig","year":"2018","unstructured":"Ludwig, K., Graf von der Schulenburg, J.M., Greiner, W.: German value set for the EQ-5D-5L. PharmacoEconomics 36(6), 663\u2013674 (2018)","journal-title":"PharmacoEconomics"},{"key":"1815_CR17","doi-asserted-by":"crossref","unstructured":"M Versteegh M, M Vermeulen K, M A A Evers S, de Wit GA, Prenger R, A Stolk E. (2016) Dutch Tariff for the Five-Level Version of EQ-5D. Value Health. 19(4):343-352","DOI":"10.1016\/j.jval.2016.01.003"},{"issue":"9","key":"1815_CR18","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s40273-019-00811-7","volume":"37","author":"D Golicki","year":"2019","unstructured":"Golicki, D., Jakubczyk, M., Graczyk, K., et al.: Valuation of EQ-5D-5L health states in Poland: the first EQ-VT-based study in Central and Eastern Europe. Pharmacoeconomics 37(9), 1165\u20131176 (2019)","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"1815_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jval.2017.10.023","volume":"21","author":"JM Ramos-Goni","year":"2018","unstructured":"Ramos-Goni, J.M., Craig, B.M., Oppe, M., et al.: Handling data quality issues to estimate the Spanish EQ-5D-5L value set using a hybrid interval regression approach. Value Health 21(5), 596\u2013604 (2018)","journal-title":"Value Health"},{"issue":"1","key":"1815_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hec.3564","volume":"27","author":"NJ Devlin","year":"2018","unstructured":"Devlin, N.J., Shah, K.K., Feng, Y., et al.: Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 27(1), 7\u201322 (2018)","journal-title":"Health Econ."},{"issue":"8","key":"1815_CR21","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","volume":"22","author":"AS Pickard","year":"2019","unstructured":"Pickard, A.S., Law, E.H., Jiang, R., et al.: United States valuation of EQ-5D-5L health states using an international protocol. Value Health. 22(8), 931\u2013941 (2019)","journal-title":"Value Health."},{"issue":"10","key":"1815_CR22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s40273-021-01043-4","volume":"39","author":"B Mulhern","year":"2021","unstructured":"Mulhern, B., Norman, R., Brazier, J.: Valuing SF-6Dv2 in Australia Using an International Protocol. Pharmacoeconomics 39(10), 1151\u20131162 (2021)","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1815_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40258-022-00715-2","volume":"20","author":"S Xie","year":"2022","unstructured":"Xie, S., Wu, J., Xie, F.: Population Norms for SF-6Dv2 and EQ-5D-5L in China. Appl. Health Econ. Health Policy 20(4), 573\u2013585 (2022)","journal-title":"Appl. Health Econ. Health Policy"},{"issue":"6","key":"1815_CR24","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/MLR.0000000000001324","volume":"58","author":"BJ Mulhern","year":"2020","unstructured":"Mulhern, B.J., Bansback, N., Norman, R., Brazier, J.: SF-6Dv2 International Project Group. Valuing the SF-6Dv2 Classification System in the United Kingdom Using a Discrete-choice Experiment With Duration. Med Care. 58(6), 566\u2013573 (2020)","journal-title":"Med Care."},{"issue":"2","key":"1815_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s40273-017-0582-5","volume":"36","author":"MT King","year":"2018","unstructured":"King, M.T., Viney, R., Simon Pickard, A., et al.: Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30. Pharmacoeconomics 36(2), 225\u2013238 (2018)","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1815_CR26","doi-asserted-by":"publisher","first-page":"238146831984253","DOI":"10.1177\/2381468319842532","volume":"4","author":"H McTaggart-Cowan","year":"2019","unstructured":"McTaggart-Cowan, H., King, M.T., Norman, R., et al.: The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30. MDM Policy Pract. 4(1), 2381468319842532 (2019)","journal-title":"MDM Policy Pract."},{"issue":"2","key":"1815_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40258-020-00598-1","volume":"19","author":"V Nerich","year":"2021","unstructured":"Nerich, V., Gamper, E.M., Norman, R., et al.: French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30. Appl. Health Econ. Health Policy 19(2), 191\u2013202 (2021)","journal-title":"Appl. Health Econ. Health Policy"},{"issue":"12","key":"1815_CR28","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1007\/s11136-019-02283-w","volume":"28","author":"G Kemmler","year":"2019","unstructured":"Kemmler, G., Gamper, E., Nerich, V., et al.: German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30. Qual. Life Res. 28(12), 3197\u20133211 (2019)","journal-title":"Qual. Life Res."},{"issue":"7","key":"1815_CR29","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s11136-021-02767-8","volume":"30","author":"F Jansen","year":"2021","unstructured":"Jansen, F., Verdonck-de Leeuw, I.M., Gamper, E., et al.: Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D. Qual. Life Res. 30(7), 2009\u20132019 (2021)","journal-title":"Qual. Life Res."},{"issue":"9","key":"1815_CR30","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s11136-020-02536-z","volume":"29","author":"EM Gamper","year":"2020","unstructured":"Gamper, E.M., King, M.T., Norman, R., et al.: EORTC QLU-C10D value sets for Austria, Italy, and Poland. Qual. Life Res. 29(9), 2485\u20132495 (2020)","journal-title":"Qual. Life Res."},{"issue":"9","key":"1815_CR31","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s40273-021-01058-x","volume":"39","author":"AP Finch","year":"2021","unstructured":"Finch, A.P., Gamper, E., Norman, R., et al.: Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment. Pharmacoeconomics 39(9), 1085\u20131098 (2021)","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"1815_CR32","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/hec.3950","volume":"28","author":"R Norman","year":"2019","unstructured":"Norman, R., Mercieca-Bebber, R., Rowen, D., et al.: UK utility weights for the EORTC QLU-C10D. Health Econ. 28(12), 1385\u20131401 (2019)","journal-title":"Health Econ."},{"issue":"4","key":"1815_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/0272989X211003569","volume":"41","author":"DA Revicki","year":"2021","unstructured":"Revicki, D.A., King, M.T., Viney, R., et al.: United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument. Med. Decis. Making 41(4), 485\u2013501 (2021)","journal-title":"Med. Decis. Making"},{"issue":"11","key":"1815_CR34","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W., Tubiana, M.: Report of the Committee on Hodgkin\u2019s Disease Staging Classification. Cancer Res. 31(11), 1860\u20131861 (1971)","journal-title":"Cancer Res."},{"issue":"26","key":"1815_CR35","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo, A., Avet-Loiseau, H., Oliva, S., et al.: Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. J. Clin. Oncol. 33(26), 2863\u20132869 (2015)","journal-title":"J. Clin. Oncol."},{"issue":"Suppl 1","key":"1815_CR36","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl, R.L., Jacene, H., Kasamon, Y., Lodge, M.A.: From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. J Nucl Med 50(Suppl 1), 122S\u201350S (2009)","journal-title":"J Nucl Med"},{"issue":"1","key":"1815_CR37","doi-asserted-by":"publisher","first-page":"2277503","DOI":"10.1080\/16078454.2023.2277503","volume":"28","author":"L Ren","year":"2023","unstructured":"Ren, L., Ren, Y., Yang, Y., et al.: Clinical profiles in multiple myeloma patients with extreme survivals: a study from a National Medical Center in China. Hematology 28(1), 2277503 (2023)","journal-title":"Hematology"},{"issue":"8476","key":"1815_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland, J.M., Altman, D.G.: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476), 307\u2013310 (1986)","journal-title":"Lancet"},{"issue":"3","key":"1815_CR39","first-page":"69","volume":"24","author":"MM Mukaka","year":"2012","unstructured":"Mukaka, M.M.: Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med. J. 24(3), 69\u201371 (2012)","journal-title":"Malawi Med. J."},{"issue":"1","key":"1815_CR40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12955-023-02202-1","volume":"21","author":"S Xie","year":"2023","unstructured":"Xie, S., Li, M., Wang, D., Hong, T., Guo, W., Wu, J.: Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China. Health Qual. Life Outcomes 21(1), 118 (2023)","journal-title":"Health Qual. Life Outcomes"},{"key":"1815_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1477-7525-11-110","volume":"11","author":"M Obradovic","year":"2013","unstructured":"Obradovic, M., Lal, A., Liedgens, H.: Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health Qual. Life Outcomes 11, 110 (2013)","journal-title":"Health Qual. Life Outcomes"},{"issue":"12","key":"1815_CR42","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s11136-017-1699-x","volume":"26","author":"AK Po\u00f3r","year":"2017","unstructured":"Po\u00f3r, A.K., Rencz, F., Brodszky, V., et al.: Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Qual. Life Res. 26(12), 3409\u20133419 (2017)","journal-title":"Qual. Life Res."},{"issue":"8","key":"1815_CR43","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10198-020-01195-8","volume":"21","author":"M Kennedy-Martin","year":"2020","unstructured":"Kennedy-Martin, M., Slaap, B., Herdman, M., van Reenen, M., Kennedy-Martin, T., Greiner, W., Busschbach, J., Boye, K.S.: Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. Eur. J. Health Econ. 21(8), 1245\u20131257 (2020)","journal-title":"Eur. J. Health Econ."}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-025-01815-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-025-01815-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-025-01815-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:02:22Z","timestamp":1775131342000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-025-01815-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1815"],"URL":"https:\/\/doi.org\/10.1007\/s10198-025-01815-1","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"22 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval from the Ethics Committee of Zhongshan Hospital, Fudan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no conflicts to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}